ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] (2022)
Pone, Boniface Kamdem ; Ferreira, Elizabeth Igne
Fonte: Current Drug Targets. Unidade: FCF
Assuntos: FLAVONOIDES, MEDICAMENTO, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONE, Boniface Kamdem e FERREIRA, Elizabeth Igne. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial]. Current Drug Targets. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/1389450123666220309093827. Acesso em: 25 out. 2025. , 2022
APA
Pone, B. K., & Ferreira, E. I. (2022). Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial]. Current Drug Targets. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.2174/1389450123666220309093827
NLM
Pone BK, Ferreira EI. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] [Internet]. Current Drug Targets. 2022 ; 23( 7): 680-682.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450123666220309093827
Vancouver
Pone BK, Ferreira EI. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] [Internet]. Current Drug Targets. 2022 ; 23( 7): 680-682.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450123666220309093827
Artigo de periodico
Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development (2022)
Pone, Kamdem Boniface ; Dalhatou, Sadou; Paumo, Hugues Kamdem ; Seru, Lebogang Maureen Katata ; Ferreira, Elizabeth Igne
Fonte: Current Drug Targets. Unidade: FCF
Assuntos: TRYPANOSOMA CRUZI, COMPOSTOS HETEROCÍCLICOS, ANTIPROTOZOÁRIOS, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONE, Kamdem Boniface et al. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development. Current Drug Targets, v. 23, n. 1, p. 33-59, 2022Tradução . . Disponível em: https://doi.org/10.2174/1389450122666210412125643. Acesso em: 25 out. 2025.
APA
Pone, K. B., Dalhatou, S., Paumo, H. K., Seru, L. M. K., & Ferreira, E. I. (2022). Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development. Current Drug Targets, 23( 1), 33-59. doi:10.2174/1389450122666210412125643
NLM
Pone KB, Dalhatou S, Paumo HK, Seru LMK, Ferreira EI. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development [Internet]. Current Drug Targets. 2022 ; 23( 1): 33-59.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450122666210412125643
Vancouver
Pone KB, Dalhatou S, Paumo HK, Seru LMK, Ferreira EI. Triazole-containing heterocycles: privileged scaffolds in anti-Trypanosoma cruzi drug development [Internet]. Current Drug Targets. 2022 ; 23( 1): 33-59.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450122666210412125643
Artigo de periodico
Vascular endothelial dysfunction in ischemic reperfusion injury needs constant updating (2022)
Soares, Ricardo Oliveira dos Santos; Albuquerque, Agnes Afrodite Sumarelli; Evora, Paulo Roberto Barbosa
Fonte: Current Drug Targets. Unidade: FMRP
Assuntos: ISQUEMIA, ENDOTÉLIO VASCULAR, SISTEMA CARDIOVASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Ricardo Oliveira dos Santos e ALBUQUERQUE, Agnes Afrodite Sumarelli e EVORA, Paulo Roberto Barbosa. Vascular endothelial dysfunction in ischemic reperfusion injury needs constant updating. Current Drug Targets, v. 23, n. 12, p. 1128-1132, 2022Tradução . . Disponível em: https://doi.org/10.2174/1389450123666220519170221. Acesso em: 25 out. 2025.
APA
Soares, R. O. dos S., Albuquerque, A. A. S., & Evora, P. R. B. (2022). Vascular endothelial dysfunction in ischemic reperfusion injury needs constant updating. Current Drug Targets, 23( 12), 1128-1132. doi:10.2174/1389450123666220519170221
NLM
Soares RO dos S, Albuquerque AAS, Evora PRB. Vascular endothelial dysfunction in ischemic reperfusion injury needs constant updating [Internet]. Current Drug Targets. 2022 ; 23( 12): 1128-1132.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450123666220519170221
Vancouver
Soares RO dos S, Albuquerque AAS, Evora PRB. Vascular endothelial dysfunction in ischemic reperfusion injury needs constant updating [Internet]. Current Drug Targets. 2022 ; 23( 12): 1128-1132.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450123666220519170221
Artigo de periodico
The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds (2021)
Boniface, Pone Kamdem ; Ferreira, Elizabeth Igne
Fonte: Current Drug Targets. Unidade: FCF
Assuntos: DOENÇAS NEGLIGENCIADAS, ANTIMALÁRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACE, Pone Kamdem e FERREIRA, Elizabeth Igne. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds. Current Drug Targets, v. 22, p. 379-398, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389450121666201228122239. Acesso em: 25 out. 2025.
APA
Boniface, P. K., & Ferreira, E. I. (2021). The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds. Current Drug Targets, 22, 379-398. doi:10.2174/1389450121666201228122239
NLM
Boniface PK, Ferreira EI. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds [Internet]. Current Drug Targets. 2021 ; 22 379-398.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450121666201228122239
Vancouver
Boniface PK, Ferreira EI. The role of nitro (NO 2-), Chloro (Cl), and Fluoro (F) substitution in the design of antileishmanial and antichagasic compounds [Internet]. Current Drug Targets. 2021 ; 22 379-398.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450121666201228122239
Artigo de periodico
An insight into the discovery of potent Antifilarial leads against lymphatic filariasis (2020)
Boniface, Pone Kamdem ; Ferreira, Elizabeth Igne
Fonte: Current Drug Targets. Unidade: FCF
Assuntos: FILARIOSE, DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACE, Pone Kamdem e FERREIRA, Elizabeth Igne. An insight into the discovery of potent Antifilarial leads against lymphatic filariasis. Current Drug Targets, v. 21, p. 657-680, 2020Tradução . . Disponível em: https://doi.org/10.2174/1389450120666191204152415. Acesso em: 25 out. 2025.
APA
Boniface, P. K., & Ferreira, E. I. (2020). An insight into the discovery of potent Antifilarial leads against lymphatic filariasis. Current Drug Targets, 21, 657-680. doi:10.2174/1389450120666191204152415
NLM
Boniface PK, Ferreira EI. An insight into the discovery of potent Antifilarial leads against lymphatic filariasis [Internet]. Current Drug Targets. 2020 ; 21 657-680.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450120666191204152415
Vancouver
Boniface PK, Ferreira EI. An insight into the discovery of potent Antifilarial leads against lymphatic filariasis [Internet]. Current Drug Targets. 2020 ; 21 657-680.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450120666191204152415
Artigo de periodico
Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods (2020)
Boniface, Pone Kamdem ; Sano, Cinthya Miyuki; Ferreira, Elizabeth Igne
Fonte: Current Drug Targets. Unidade: FCF
Assuntos: LEISHMANIA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACE, Pone Kamdem e SANO, Cinthya Miyuki e FERREIRA, Elizabeth Igne. Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods. Current Drug Targets, v. 21, p. 681-712, 2020Tradução . . Disponível em: https://doi.org/10.2174/1389450121666200128112948. Acesso em: 25 out. 2025.
APA
Boniface, P. K., Sano, C. M., & Ferreira, E. I. (2020). Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods. Current Drug Targets, 21, 681-712. doi:10.2174/1389450121666200128112948
NLM
Boniface PK, Sano CM, Ferreira EI. Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods [Internet]. Current Drug Targets. 2020 ; 21 681-712.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450121666200128112948
Vancouver
Boniface PK, Sano CM, Ferreira EI. Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods [Internet]. Current Drug Targets. 2020 ; 21 681-712.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450121666200128112948
Artigo de periodico
Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy (2019)
Oliveira-Paula, Gustavo H.; Tanus-Santos, José Eduardo
Fonte: Current Drug Targets. Unidade: FMRP
Assuntos: HIPERTENSÃO, ÓXIDO NÍTRICO, NITRATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-PAULA, Gustavo H. e TANUS-SANTOS, José Eduardo. Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy. Current Drug Targets, v. 20, n. 4, p. 431-443, 2019Tradução . . Disponível em: https://doi.org/10.2174/1389450119666180816120816. Acesso em: 25 out. 2025.
APA
Oliveira-Paula, G. H., & Tanus-Santos, J. E. (2019). Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy. Current Drug Targets, 20( 4), 431-443. doi:10.2174/1389450119666180816120816
NLM
Oliveira-Paula GH, Tanus-Santos JE. Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy [Internet]. Current Drug Targets. 2019 ; 20( 4): 431-443.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450119666180816120816
Vancouver
Oliveira-Paula GH, Tanus-Santos JE. Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy [Internet]. Current Drug Targets. 2019 ; 20( 4): 431-443.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450119666180816120816
Artigo de periodico
Advances and challenges in drug design of PPARδ ligands (2018)
Maltarollo, Vinícius Gonçalves ; Kronenberger, Thales ; Windshuegel, Bjoern ; Wrenger, Carsten ; Trossini, Gustavo Henrique Goulart ; Honório, Káthia Maria
Fonte: Current Drug Targets. Unidades: ICB, FCF, EACH
Assuntos: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, SÍNDROME X METABÓLICA, ÁCIDOS GRAXOS, DOENÇAS METABÓLICAS, PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinícius Gonçalves et al. Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, v. 19, n. 2, p. 144-154, 2018Tradução . . Disponível em: https://doi.org/10.2174/1389450118666170414113159. Acesso em: 25 out. 2025.
APA
Maltarollo, V. G., Kronenberger, T., Windshuegel, B., Wrenger, C., Trossini, G. H. G., & Honório, K. M. (2018). Advances and challenges in drug design of PPARδ ligands. Current Drug Targets, 19( 2), 144-154. doi:10.2174/1389450118666170414113159
NLM
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450118666170414113159
Vancouver
Maltarollo VG, Kronenberger T, Windshuegel B, Wrenger C, Trossini GHG, Honório KM. Advances and challenges in drug design of PPARδ ligands [Internet]. Current Drug Targets. 2018 ; 19( 2): 144-154.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450118666170414113159
Artigo de periodico
The chemopreventive activity of β-ionone involves modulation of Rxrα, Rarβ and Coup-Tf1 expression in liver pre-neoplastic lesions in rats (2015)
Cardozo, M. T; Furtado, kelly Silva; De Conti, Aline; Andrade, F. de Oliveira; Fernandes, L. H; Campos, A; Scolastici, C; Moreno, Fernando Salvador
Fonte: Current Drug Targets. Unidade: FCF
Assuntos: CARCINOGÊNESE ANIMAL, CARCINOMA HEPATOCELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOZO, M. T et al. The chemopreventive activity of β-ionone involves modulation of Rxrα, Rarβ and Coup-Tf1 expression in liver pre-neoplastic lesions in rats. Current Drug Targets, 2015Tradução . . Disponível em: https://doi.org/10.2174/1389450116666151001110507. Acesso em: 25 out. 2025.
APA
Cardozo, M. T., Furtado, kelly S., De Conti, A., Andrade, F. de O., Fernandes, L. H., Campos, A., et al. (2015). The chemopreventive activity of β-ionone involves modulation of Rxrα, Rarβ and Coup-Tf1 expression in liver pre-neoplastic lesions in rats. Current Drug Targets. doi:10.2174/1389450116666151001110507
NLM
Cardozo MT, Furtado kelly S, De Conti A, Andrade F de O, Fernandes LH, Campos A, Scolastici C, Moreno FS. The chemopreventive activity of β-ionone involves modulation of Rxrα, Rarβ and Coup-Tf1 expression in liver pre-neoplastic lesions in rats [Internet]. Current Drug Targets. 2015 ;[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450116666151001110507
Vancouver
Cardozo MT, Furtado kelly S, De Conti A, Andrade F de O, Fernandes LH, Campos A, Scolastici C, Moreno FS. The chemopreventive activity of β-ionone involves modulation of Rxrα, Rarβ and Coup-Tf1 expression in liver pre-neoplastic lesions in rats [Internet]. Current Drug Targets. 2015 ;[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/1389450116666151001110507
Artigo de periodico
Inducible nitric oxide synthase as a possible target in hypertension (2014)
Oliveira-Paula, Gustavo H; Lacchini, Riccardo ; Tanus-Santos, José Eduardo
Fonte: Current Drug Targets. Unidades: EERP, FMRP
Assuntos: FÁRMACOS (SISTEMA CARDIOVASCULAR), MODELOS ANIMAIS DE DOENÇAS, HIPERTENSÃO, ÓXIDO NÍTRICO, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-PAULA, Gustavo H e LACCHINI, Riccardo e TANUS-SANTOS, José Eduardo. Inducible nitric oxide synthase as a possible target in hypertension. Current Drug Targets, v. 15, n. 2, p. 164-174, 2014Tradução . . Disponível em: https://doi.org/10.2174/13894501113146660227. Acesso em: 25 out. 2025.
APA
Oliveira-Paula, G. H., Lacchini, R., & Tanus-Santos, J. E. (2014). Inducible nitric oxide synthase as a possible target in hypertension. Current Drug Targets, 15( 2), 164-174. doi:10.2174/13894501113146660227
NLM
Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Inducible nitric oxide synthase as a possible target in hypertension [Internet]. Current Drug Targets. 2014 ; 15( 2): 164-174.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/13894501113146660227
Vancouver
Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Inducible nitric oxide synthase as a possible target in hypertension [Internet]. Current Drug Targets. 2014 ; 15( 2): 164-174.[citado 2025 out. 25 ] Available from: https://doi.org/10.2174/13894501113146660227
Artigo de periodico
PAF receptor and tumor growth (2014)
Jancar, Sonia ; Chammas, Roger
Fonte: Current Drug Targets. Unidades: ICB, FM
Assuntos: IMUNOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, PLAQUETAS SANGUÍNEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANCAR, Sonia e CHAMMAS, Roger. PAF receptor and tumor growth. Current Drug Targets, v. 15, n. 10, p. 982-987, 2014Tradução . . Acesso em: 25 out. 2025.
APA
Jancar, S., & Chammas, R. (2014). PAF receptor and tumor growth. Current Drug Targets, 15( 10), 982-987.
NLM
Jancar S, Chammas R. PAF receptor and tumor growth. Current Drug Targets. 2014 ; 15( 10): 982-987.[citado 2025 out. 25 ]
Vancouver
Jancar S, Chammas R. PAF receptor and tumor growth. Current Drug Targets. 2014 ; 15( 10): 982-987.[citado 2025 out. 25 ]
Artigo de periodico
Matrix metalloproteinases as drug targets in preeclampsia (2013)
Palei, Ana C. T.; Granger, Joey P.; Tanus-Santos, José Eduardo
Fonte: Current Drug Targets. Unidade: FMRP
Assuntos: HIPERTENSÃO, METALOPROTEINASES, PRÉ-ECLÂMPSIA, GRAVIDEZ (COMPLICAÇÕES)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALEI, Ana C. T. e GRANGER, Joey P. e TANUS-SANTOS, José Eduardo. Matrix metalloproteinases as drug targets in preeclampsia. Current Drug Targets, v. 14, n. 3, p. 325-334, 2013Tradução . . Acesso em: 25 out. 2025.
APA
Palei, A. C. T., Granger, J. P., & Tanus-Santos, J. E. (2013). Matrix metalloproteinases as drug targets in preeclampsia. Current Drug Targets, 14( 3), 325-334.
NLM
Palei ACT, Granger JP, Tanus-Santos JE. Matrix metalloproteinases as drug targets in preeclampsia. Current Drug Targets. 2013 ; 14( 3): 325-334.[citado 2025 out. 25 ]
Vancouver
Palei ACT, Granger JP, Tanus-Santos JE. Matrix metalloproteinases as drug targets in preeclampsia. Current Drug Targets. 2013 ; 14( 3): 325-334.[citado 2025 out. 25 ]
Artigo de periodico
Anticarcinogenic actions of tributyrin,a butyric acid prodrug (2012)
Heidor, Renato ; Ortega, Juliana Festa; Conti, Aline de; Ong, Thomas Prates ; Moreno, Fernando Salvador
Fonte: Current Drug Targets. Unidade: FCF
Assuntos: ANTINEOPLÁSICOS, ENSAIO CLÍNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HEIDOR, Renato et al. Anticarcinogenic actions of tributyrin,a butyric acid prodrug. Current Drug Targets, v. 13, n. 14, p. 1720-1729, 2012Tradução . . Acesso em: 25 out. 2025.
APA
Heidor, R., Ortega, J. F., Conti, A. de, Ong, T. P., & Moreno, F. S. (2012). Anticarcinogenic actions of tributyrin,a butyric acid prodrug. Current Drug Targets, 13( 14), 1720-1729.
NLM
Heidor R, Ortega JF, Conti A de, Ong TP, Moreno FS. Anticarcinogenic actions of tributyrin,a butyric acid prodrug. Current Drug Targets. 2012 ; 13( 14): 1720-1729.[citado 2025 out. 25 ]
Vancouver
Heidor R, Ortega JF, Conti A de, Ong TP, Moreno FS. Anticarcinogenic actions of tributyrin,a butyric acid prodrug. Current Drug Targets. 2012 ; 13( 14): 1720-1729.[citado 2025 out. 25 ]
Artigo de periodico
Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway: a critical overview (2012)
Évora, Paulo Roberto Barbosa; Evora, Patrícia Martinez; Celotto, Andrea C.; Rodrigues, Alfredo José; Joviliano, Edwaldo Edner
Fonte: Current Drug Targets. Unidade: FMRP
Assuntos: ÓXIDO NÍTRICO, DOENÇAS CARDIOVASCULARES, ENDOTÉLIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ÉVORA, Paulo Roberto Barbosa et al. Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway: a critical overview. Current Drug Targets, v. 13, n. 9, p. 1207-1214, 2012Tradução . . Acesso em: 25 out. 2025.
APA
Évora, P. R. B., Evora, P. M., Celotto, A. C., Rodrigues, A. J., & Joviliano, E. E. (2012). Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway: a critical overview. Current Drug Targets, 13( 9), 1207-1214.
NLM
Évora PRB, Evora PM, Celotto AC, Rodrigues AJ, Joviliano EE. Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway: a critical overview. Current Drug Targets. 2012 ; 13( 9): 1207-1214.[citado 2025 out. 25 ]
Vancouver
Évora PRB, Evora PM, Celotto AC, Rodrigues AJ, Joviliano EE. Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway: a critical overview. Current Drug Targets. 2012 ; 13( 9): 1207-1214.[citado 2025 out. 25 ]
Artigo de periodico
Mild mitochondrial uncoupling as a therapeutic strategy (2011)
Cunha, Fernanda Marques da; Caldeira da Silva, Camille C; Cerqueira, Fernanda M; Kowaltowski, Alicia Juliana
Fonte: Current Drug Targets. Unidades: EACH, IQ
Assuntos: MITOCÔNDRIAS, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUNHA, Fernanda Marques da et al. Mild mitochondrial uncoupling as a therapeutic strategy. Current Drug Targets, v. 12, n. 6, p. 783-789, 2011Tradução . . Acesso em: 25 out. 2025.
APA
Cunha, F. M. da, Caldeira da Silva, C. C., Cerqueira, F. M., & Kowaltowski, A. J. (2011). Mild mitochondrial uncoupling as a therapeutic strategy. Current Drug Targets, 12( 6), 783-789.
NLM
Cunha FM da, Caldeira da Silva CC, Cerqueira FM, Kowaltowski AJ. Mild mitochondrial uncoupling as a therapeutic strategy. Current Drug Targets. 2011 ; 12( 6): 783-789.[citado 2025 out. 25 ]
Vancouver
Cunha FM da, Caldeira da Silva CC, Cerqueira FM, Kowaltowski AJ. Mild mitochondrial uncoupling as a therapeutic strategy. Current Drug Targets. 2011 ; 12( 6): 783-789.[citado 2025 out. 25 ]
Artigo de periodico
Current treatment and drug discovery against leishmania spp. and plasmodium spp.: a review (2009)
Cruz, Ângela Kaysel; Toledo, Juliano Simões de; Falade, Mofolusho; Terrão, Mônicas Cristina; Kamchonwongpaisan, Sumalee; Kyle, Dennis E.; Uthaipibull, Chairat
Fonte: Current Drug Targets. Unidade: FMRP
Assuntos: LEISHMANIA, MALÁRIA, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZ, Ângela Kaysel et al. Current treatment and drug discovery against leishmania spp. and plasmodium spp.: a review. Current Drug Targets, v. 10, n. 3, p. 178-192, 2009Tradução . . Acesso em: 25 out. 2025.
APA
Cruz, Â. K., Toledo, J. S. de, Falade, M., Terrão, M. C., Kamchonwongpaisan, S., Kyle, D. E., & Uthaipibull, C. (2009). Current treatment and drug discovery against leishmania spp. and plasmodium spp.: a review. Current Drug Targets, 10( 3), 178-192.
NLM
Cruz ÂK, Toledo JS de, Falade M, Terrão MC, Kamchonwongpaisan S, Kyle DE, Uthaipibull C. Current treatment and drug discovery against leishmania spp. and plasmodium spp.: a review. Current Drug Targets. 2009 ; 10( 3): 178-192.[citado 2025 out. 25 ]
Vancouver
Cruz ÂK, Toledo JS de, Falade M, Terrão MC, Kamchonwongpaisan S, Kyle DE, Uthaipibull C. Current treatment and drug discovery against leishmania spp. and plasmodium spp.: a review. Current Drug Targets. 2009 ; 10( 3): 178-192.[citado 2025 out. 25 ]
Artigo de periodico
Protein crystallography in drug discovery (2008)
Canduri, Fernanda ; Azevedo Junior, Walter Filgueira de
Fonte: Current Drug Targets. Unidade: IQSC
Assuntos: BIOQUÍMICA, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANDURI, Fernanda e AZEVEDO JUNIOR, Walter Filgueira de. Protein crystallography in drug discovery. Current Drug Targets, v. 9, n. 12, p. 1048-1053, 2008Tradução . . Acesso em: 25 out. 2025.
APA
Canduri, F., & Azevedo Junior, W. F. de. (2008). Protein crystallography in drug discovery. Current Drug Targets, 9( 12), 1048-1053.
NLM
Canduri F, Azevedo Junior WF de. Protein crystallography in drug discovery. Current Drug Targets. 2008 ; 9( 12): 1048-1053.[citado 2025 out. 25 ]
Vancouver
Canduri F, Azevedo Junior WF de. Protein crystallography in drug discovery. Current Drug Targets. 2008 ; 9( 12): 1048-1053.[citado 2025 out. 25 ]
Artigo de periodico
Unconventional strategies for the suppression of alergic asthma (2003)
Mucida, Daniel de Sousa ; Keller, Alexandre de Castro; Fernvik, Eva Christina; Russo, Momtchilo
Fonte: Current Drug Targets. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUCIDA, Daniel de Sousa et al. Unconventional strategies for the suppression of alergic asthma. Current Drug Targets, v. 2, p. 187-195, 2003Tradução . . Acesso em: 25 out. 2025.
APA
Mucida, D. de S., Keller, A. de C., Fernvik, E. C., & Russo, M. (2003). Unconventional strategies for the suppression of alergic asthma. Current Drug Targets, 2, 187-195.
NLM
Mucida D de S, Keller A de C, Fernvik EC, Russo M. Unconventional strategies for the suppression of alergic asthma. Current Drug Targets. 2003 ; 2 187-195.[citado 2025 out. 25 ]
Vancouver
Mucida D de S, Keller A de C, Fernvik EC, Russo M. Unconventional strategies for the suppression of alergic asthma. Current Drug Targets. 2003 ; 2 187-195.[citado 2025 out. 25 ]
Artigo de periodico
An approach for the rational design of new antituberculosis agents (2001)
Pasqualoto, Kerly Fernanda Mesquita; Ferreira, Elizabeth Igne
Fonte: Current Drug Targets. Unidade: FCF
Assuntos: MICOBACTERIOSE, TUBERCULOSE, QUIMIOTERÁPICOS, PLANEJAMENTO DE FÁRMACOS, QUÍMICA FARMACÊUTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASQUALOTO, Kerly Fernanda Mesquita e FERREIRA, Elizabeth Igne. An approach for the rational design of new antituberculosis agents. Current Drug Targets, v. 2, n. 4, p. 427-437, 2001Tradução . . Acesso em: 25 out. 2025.
APA
Pasqualoto, K. F. M., & Ferreira, E. I. (2001). An approach for the rational design of new antituberculosis agents. Current Drug Targets, 2( 4), 427-437.
NLM
Pasqualoto KFM, Ferreira EI. An approach for the rational design of new antituberculosis agents. Current Drug Targets. 2001 ; 2( 4): 427-437.[citado 2025 out. 25 ]
Vancouver
Pasqualoto KFM, Ferreira EI. An approach for the rational design of new antituberculosis agents. Current Drug Targets. 2001 ; 2( 4): 427-437.[citado 2025 out. 25 ]

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Indexado em

Afiliação dos autores externos não normalizada